Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 2, 2009, Pages

  Sun, Xiaofeng ^a   Cárdenas, Andrés ^a,b   Wu, Yan ^a   Enjyoji, Keichi ^a   Robson, Simon C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

ATP; Ectonucleotidase; Gastrointestinal bleeding; Nitric oxide; Portal vein stenosis; Splanchnic hemodynamics

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; CATECHOLAMINE; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; NITRIC OXIDE; NUCLEOTIDASE; PROTEIN CD39; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; HEMODYNAMICS; INFLAMMATION; INTESTINAL BLEEDING; MOUSE; NONHUMAN; OXYGEN TENSION; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW;

ACUTE DISEASE; ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; CAPILLARY PERMEABILITY; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; GASTROINTESTINAL HEMORRHAGE; HYPERTENSION, PORTAL; LIGATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROCIRCULATION; NITRIC OXIDE; PORTAL PRESSURE; PORTAL VEIN; SPLANCHNIC CIRCULATION; TIME FACTORS;

EID: 68049105376     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90703.2008     Document Type: Article

References (34)

1. Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 102: 931-935, 1992.
2. Aller MA, Vara E, Garcia C, Palma MD, Arias JL, Nava MP, Arias J. Proinflammatory liver and anti-inflammatory intestinal mediators involved in portal hypertensive rats. Mediators Inflamm 2005: 101-111, 2005.
3. Atkinson B, Dwyer K, Enjyoji K, Robson SC. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells Mol Dis 36: 217-222, 2006.
4. Beldi G, Enjyoji K, Wu Y, Miller L, Banz Y, Sun X, Robson SC. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism. Front Biosci 13: 2588-2603, 2008.
5. Beldi G, Wu Y, Sun X, Imai M, Enjyoji K, Csizmadia E, Candinas D, Erb L, Robson SC. Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration. Gastroenterology 135: 1751-1760, 2008.
6. Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 11: 755-759, 1999.
7. Cardenas A, Lowe R, Oh S, Bodkin S, Kenney T, Lamorte WW, Afdhal NH. Hemodynamic effects of substance P and its receptor antagonist RP67580 in anesthetized rats with carbon tetrachloride-induced cirrhosis. Scand J Gastroenterol 43: 328-333, 2008.
8. Dranoff JA, Kruglov EA, Robson SC, Braun N, Zimmermann H, Sevigny J. The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver. Hepatology 36: 1135-1144, 2002.
9. Eltzschig HK, Kohler D, Eckle T, Kong T, Robson SC, Colgan SP. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113: 224-232, 2009.
10. Enjyoji K, Kotani K, Thukral C, Blumel B, Sun X, Wu Y, Imai M, Friedman D, Csizmadia E, Bleibel W, Kahn BB, Robson SC. Deletion of cd39/entpd1 results in hepatic insulin resistance. Diabetes 57: 2311-2320, 2008.
11. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thrombo-regulation. Nat Med 5: 1010-1017, 1999.
12. Fernandez M, Vizzutti F, Garcia-Pagan JC, Rodes J, Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 126: 886-894, 2004.
13. Fernando B, Marley R, Holt S, Anand R, Harry D, Sanderson P, Smith R, Hamilton G, Moore K. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 28: 689-694, 1998.
14. Forrest EH, Bouchier IA, Hayes PC. Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis. Gut 40: 139-144, 1997.
15. Geerts AM, De Vriese AS, Vanheule E, Van Vlierberghe H, Mortier S, Cheung KJ, Demetter P, Lameire N, De Vos M, Colle I. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study. Liver Int 26: 889-898, 2006.
16. Guckelberger O, Sun XF, Sevigny J, Imai M, Kaczmarek E, Enjyoji K, Kruskal JB, Robson SC. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost 91: 576-586, 2004.
17. Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. Am J Physiol Gastrointest Liver Physiol 283: G1074-G1081, 2002.
18. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43: S121-S131, 2006.
19. Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med 345: 1683-1688, 2001.
20. Lange S, Delbro DS, Jennische E. Evans blue permeation of intestinal mucosa in the rat. Scand J Gastroenterol 29: 38-46, 1994.
21. Lee SS, Chilton EL, Pak JM. Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats. Hepatology 15: 1107-1111, 1992.
22. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 108: 761-767, 1995.
23. Melgar-Lesmes P, Tugues S, Ros J, Fernandez-Varo G, Morales-Ruiz M, Rodes J, Jimenez W. Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats. Gut 58: 285-292, 2009.
24. Moezi L, Gaskari SA, Lee SS. Endocannabinoids and liver disease. V. Endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis. Am J Physiol Gastrointest Liver Physiol 295: G649-G653, 2008.
25. Narravula S, Lennon PF, Mueller BU, Colgan SP. Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J Immunol 165: 5262-5268, 2000.
26. Robson SC, Sevigny J, Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2: 409-430, 2006.
27. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10: 195-202, 2009.
28. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 28: 26-42, 2008.
29. Vial C, Evans RJ. P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol 62: 1438-1445, 2002.
30. Wang JJ, Gao GW, Gao RZ, Liu CA, Ding X, Yao ZX. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension. World J Gastroenterol 10: 689-693, 2004.
31. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 41: 422-433, 2005.
32. Wihlborg AK, Malmsjo M, Eyjolfsson A, Gustafsson R, Jacobson K, Erlinge D. Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyper-polarising factor. Br J Pharmacol 138: 1451-1458, 2003.
33. Yamaguchi S, Kawanaka H, Yoshida D, Maehara Y, Hashizume M. Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis. Life Sci 80: 2036-2044, 2007.
34. Yao GX, Shen ZY, Xue XB, Yang Z. Intestinal permeability in rats with CCl4-induced portal hypertension. World J Gastroenterol 12: 479-481, 2006.